Daniel W. Muehl

Insider Reports History

Identity 1 identity field
Location
North Billerca, MA
SEC source record 1 source field
Owner filing signature
/s/ Daniel Muehl
SEC evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Daniel W. Muehl

Form 4 holding Executive Vice President and Chief Financial Officer

Clovis Oncology, Inc.

Security class
Common Stock
Shares / value
104,830
Estimated value
$103,037
Report date
02 Nov 2022
Price
$0.9829
Ownership
Direct
Form 4 holding Executive Vice President and Chief Financial Officer

Clovis Oncology, Inc.

Security class
Restricted Stock Units
Shares / value
23,125
Estimated value
Report date
01 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Daniel W. Muehl

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .